as on October 3, 2025 at 4:01 pm IST
Day's Low
Day's High
2.76%
Downside
1.10%
Upside
52 Week's Low
52 Week's High
41.87%
Downside
22.13%
Upside
as on October 3, 2025 at 4:01 pm IST
Market Cap
₹621.43 Cr
Return on Equity (ROE)
8.1
PE Ratio (TTM)
11.57
Return on capital employed (ROCE)
11.75
Industry PE ratio
41.24
Beta (LTM)
1.01
P/B Ratio
0.68
Dividend Yield
0PEG Ratio
0.61
Quarterly Earnings Growth YOY
686.89
EPS (TTM)
33.9
Sector
Pharmaceuticals
Book Value
419.65
Technical Analysis
Bullish
View Technical Analysis
as on October 3, 2025 at 4:01 pm IST
Venus Remedies in the last 5 years
Lowest (-45.34x)
September 23, 2020
Today (11.57x)
October 3, 2025
Industry (41.24x)
October 3, 2025
Highest (21.70x)
December 28, 2023
Today’s Price to Earnings Ratio: 11.57x
Compare market cap, revenue, PE, and other key metrics of Venus Remedies with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 621.43 | 41.8% | 0.50 | 45 | 647 | |
NA | 39.22 | -5.42% | 0.82 | 3 | 168 | |
NA | 348.33 | 84.39% | 0.64 | 7 | 138 | |
BUY | 20,682.11 | 1.12% | 0.57 | -18 | 1,444 | |
BUY | 19,514.26 | 232.9% | 0.55 | 260 | 1,476 |
Search interest for Venus Remedies Ltd Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:5% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Venus Remedies.
Venus Remedies Ltd’s net profit jumped 686.89% since last year same period to ₹9.60Cr in the Q1 2025-2026. On a quarterly growth basis, Venus Remedies Ltd has generated -54.29% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2013, Venus Remedies Ltd has declared dividend of ₹3.00 per share on 20 May 2013 - translating a dividend yield of 1.32%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 6 months, VENUSREM stock has moved up by 39.2%
FII Holding Up
Foreign Institutions have increased holdings from 1.34% to 2.24% in Jun 2025 quarter
Best in 1 Year
In the last 1 year, VENUSREM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 128.2% return, outperforming this stock by 10.1%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 41.76% of holdings in Jun 2025 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 201.73 Cr → 140.59 Cr (in ₹), with an average decrease of 30.3% per quarter
Profit Down
Netprofit is down for the last 2 quarters, 21.0 Cr → 9.6 Cr (in ₹), with an average decrease of 54.3% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 56.90% to 55.89% in Jun 2025 quarter
Organisation | Venus Remedies Ltd |
Headquarters | Panchkula |
Industry | Pharmaceuticals |
CEO | Pawan Chaudhary |
E-voting on shares | Click here to vote |
Venus Remedies share price today stands at ₹464.9 as on at the close of the market. Venus Remedies share today touched a day high of ₹470 and a low of ₹452.05.
Venus Remedies touched a 52 week high of ₹567.8 and a 52 week low of ₹270.25. Venus Remedies share price today i.e. is closed at ₹464.9, which is -18.12% down from its 52 week high and 72.03% up from its 52 week low.
Venus Remedies market capitalisation is ₹621.43 Cr as on .
To buy Venus Remedies shares, you need to follow these steps:
Venus Remedies trading volume is 38.20K as on . This means that 38.20K shares of Venus Remedies were bought and sold on the stock market during today's trading session.